Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Clindamycin phosphate - Generic Drug Details

« Back to Dashboard

What are the generic sources for clindamycin phosphate and what is the scope of clindamycin phosphate patent protection?

Clindamycin phosphate
is the generic ingredient in sixteen branded drugs marketed by Alvogen Inc, Watson Labs, Pharmacia And Upjohn, Mylan Pharms Inc, Wockhardt, Loch, West-ward Pharms Int, Bristol Myers Squibb, Sagent Pharms, Ingenus Pharms Llc, Sagent Strides, G And W Labs Inc, Marsam Pharms Llc, Akorn, Solopak, Abbvie, Igi Labs Inc, Paddock Llc, Vintage Pharms, Abraxis Pharm, Perrigo, Fougera Pharms, Teva Parenteral, Boca Pharma Llc, Teligent Pharma Inc, Fresenius Kabi Usa, Akorn Inc, Baxter Hlthcare, Perrigo New York, Fougera Pharms Inc, Bedford, Precision Dermat, Taro Pharm Inds, Perrigo Uk Finco, Sandoz Inc, Perrigo Pharma Intl, Medicis, Aqua Pharms Llc, and Actavis Mid Atlantic, and is included in sixty-five NDAs. There are seven patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Clindamycin phosphate has one hundred and ten patent family members in thirty-six countries.

There are fifty-two drug master file entries for clindamycin phosphate. Thirty-two suppliers are listed for this compound.

Summary for Generic Name: clindamycin phosphate

Tradenames:16
Patents:7
Applicants:39
NDAs:65
Drug Master File Entries: see list52
Suppliers / Packagers: see list32
Bulk Api Vendors: see list54
Clinical Trials: see list416
Patent Applications: see list1,636
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:clindamycin phosphate at DailyMed

Pharmacology for Ingredient: clindamycin phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
clindamycin phosphate
INJECTABLE;INJECTION050648-003Dec 29, 1989DISCNNoNo► Subscribe► Subscribe
Fougera Pharms Inc
CLINDAMYCIN PHOSPHATE
clindamycin phosphate
SOLUTION;TOPICAL064159-001Jun 5, 1997ATRXNoNo► Subscribe► Subscribe
Teva Parenteral
CLINDAMYCIN PHOSPHATE
clindamycin phosphate
INJECTABLE;INJECTION063282-001May 29, 1992DISCNNoNo► Subscribe► Subscribe
Abbvie
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
clindamycin phosphate
INJECTABLE;INJECTION065027-003Jun 29, 2001DISCNNoNo► Subscribe► Subscribe
Abbvie
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
clindamycin phosphate
INJECTABLE;INJECTION065027-002Jun 29, 2001DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Formulary management
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot